Clinical Trial Update: The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial evaluated the effects of memantine on brain structure and chemistry in patients with Alzheimer's disease. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Stanford University | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-04-07